Flattish revenue growth for FY26
Management expects full-year revenue to be flattish YoY, with Q4 showing growth but not enough to offset earlier declines.
Dhanuka Agritech · forward-looking guidance across the available source record.
Guidance tracker
Management expects full-year revenue to be flattish YoY, with Q4 showing growth but not enough to offset earlier declines.
Management expects full-year EBITDA margin to decline by 100-110 basis points compared to FY25.
The Dahej plant is expected to achieve 80% capacity utilization in FY27 with three products (bifenthrin, defenoconazole, and a new product).
Dhanuka plans to launch three new products in FY27, including two fungicides (first-time introductions) and a spray efficiency enhancer.